Cargando…

Editorial: Platelet and megakaryocyte dysfunctions in infectious diseases

Detalles Bibliográficos
Autores principales:	Assinger, Alice, Capron, Claude, Real, Fernando, Bomsel, Morgane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086536/ https://www.ncbi.nlm.nih.gov/pubmed/37056755 http://dx.doi.org/10.3389/fimmu.2023.1175200

Ejemplares similares

HIV-Sheltering Platelets From Immunological Non-Responders Induce a Dysfunctional Glycolytic CD4(+) T-Cell Profile
por: Zhu, Aiwei, et al.
Publicado: (2022)

Transcription factors in megakaryocytes and platelets
por: Yuan, Hengjie, et al.
Publicado: (2023)

Infection of lung megakaryocytes and platelets by SARS-CoV-2 anticipate fatal COVID-19
por: Zhu, Aiwei, et al.
Publicado: (2022)

Platelets and Infection – An Emerging Role of Platelets in Viral Infection
por: Assinger, Alice
Publicado: (2014)

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination
por: Bomsel, Morgane, et al.
Publicado: (2023)

Generation of HLA Universal Megakaryocytes and Platelets by Genetic Engineering
por: Figueiredo, Constanca, et al.
Publicado: (2021)

Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis
por: Ruiz, Maria Julia, et al.
Publicado: (2022)

Protocol to detect infectious SARS-CoV-2 at low levels using in situ hybridization techniques
por: Cottignies-Calamarte, Andréa, et al.
Publicado: (2023)

Platelets in Sepsis: An Update on Experimental Models and Clinical Data
por: Assinger, Alice, et al.
Publicado: (2019)

Platelets in Viral Infections – Brave Soldiers or Trojan Horses
por: Schrottmaier, Waltraud C., et al.
Publicado: (2022)

The Human Penis Is a Genuine Immunological Effector Site
por: Sennepin, Alexis, et al.
Publicado: (2017)

The Protective HIV-1 Envelope gp41 Antigen P1 Acts as a Mucosal Adjuvant Stimulating the Innate Immunity
por: Xu, Lin, et al.
Publicado: (2021)

Effects of Estrogens on Platelets and Megakaryocytes
por: Dupuis, Marion, et al.
Publicado: (2019)

In vitro Generation of Megakaryocytes and Platelets
por: Liu, Huicong, et al.
Publicado: (2021)

Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
por: Cottignies-Calamarte, Andréa, et al.
Publicado: (2023)

Editorial: Epigenetics of infectious diseases
por: Kulkarni, Smita, et al.
Publicado: (2022)

Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes
Publicado: (1981)

Apoptosis in megakaryocytes: Safeguard and threat for thrombopoiesis
por: Yang, Shuo, et al.
Publicado: (2023)

Antibody-Dependent Cellular Phagocytosis of HIV-1-Infected Cells Is Efficiently Triggered by IgA Targeting HIV-1 Envelope Subunit gp41
por: Duchemin, Maxence, et al.
Publicado: (2020)

Occurrence and role of lung megakaryocytes in infection and inflammation
por: Gelon, Lucie, et al.
Publicado: (2022)

Megakaryocyte rupture for acute platelet needs
por: Nieswandt, Bernhard, et al.
Publicado: (2015)

The role of platelets and megakaryocytes in bone metastasis
por: Leblanc, Raphael, et al.
Publicado: (2016)

Genomics and transcriptomics of megakaryocytes and platelets: Implications for health and disease
por: Fisher, Marlie H., et al.
Publicado: (2018)

Megakaryocyte and Platelet Transcriptomics for Discoveries in Human Health and Disease
por: Davizon-Castillo, Pavel, et al.
Publicado: (2020)

IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis
por: Duchemin, Maxence, et al.
Publicado: (2018)

From Human Megakaryocytes to Platelets: Effects of Aspirin on High-Mobility Group Box 1/Receptor for Advanced Glycation End Products Axis
por: Mardente, Stefania, et al.
Publicado: (2018)

Editorial: The Mononuclear Phagocyte System in Infectious Disease
por: Lugo-Villarino, Geanncarlo, et al.
Publicado: (2019)

Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2020)

Editorial: Nanoparticle Vaccines Against Infectious Diseases
por: Reljic, Rajko, et al.
Publicado: (2019)

Editorial: Immuno-Epigenetic Markers for Infectious Diseases
por: dos Santos, Eduardo José Melo, et al.
Publicado: (2019)

Editorial: Sexual Dimorphism of the Immune Inflammatory Response in Infectious and Non-infectious Diseases
por: Chamekh, Mustapha, et al.
Publicado: (2019)

The heterogeneity of megakaryocytes and platelets and implications for ex vivo platelet generation
por: Liu, Cuicui, et al.
Publicado: (2021)

Reprogramming megakaryocytes to engineer platelets as delivery vehicles
por: Javdan, Shwan B., et al.
Publicado: (2023)

Manipulating megakaryocytes to manufacture platelets ex vivo
por: Karagiannis, P, et al.
Publicado: (2015)

The platelet fibrinogen receptor: from megakaryocyte to the mortuary
por: Floyd, Christopher N, et al.
Publicado: (2012)

Interactions of periodontal pathogens with megakaryocytic cells and platelets
por: Andrews, A.M., et al.
Publicado: (2017)

The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes
por: De Kock, Lore, et al.
Publicado: (2020)

Editorial: Aquatic Invertebrate Immunity Against Infectious Diseases
por: Perazzolo, Luciane Maria, et al.
Publicado: (2021)

Editorial: Megakaryocytes as regulators of tumor microenvironments
por: Migliaccio, Anna Rita, et al.
Publicado: (2022)

Platelets—Disarmed guardians in the fight against the plague
por: Assinger, Alice
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hr4t6gg0ssk98hrtb08nuaq6g7